TimesSquare Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.9M | Sell |
571,242
-174,309
| -23% | -$5.46M | 0.26% | 119 |
|
|
2025
Q1 | $25M | Sell |
745,551
-103,299
| -12% | -$3.47M | 0.4% | 89 |
|
|
2024
Q4 | $33.3M | Buy |
848,850
+70,557
| +9% | +$2.77M | 0.48% | 90 |
|
|
2024
Q3 | $30.6M | Buy |
778,293
+23,800
| +3% | +$937K | 0.46% | 87 |
|
|
2024
Q2 | $29.4M | Buy |
754,493
+17,320
| +2% | +$675K | 0.46% | 87 |
|
|
2024
Q1 | $31.7M | Sell |
737,173
-56,781
| -7% | -$2.44M | 0.46% | 90 |
|
|
2023
Q4 | $36.6M | Buy |
793,954
+203,379
| +34% | +$9.37M | 0.54% | 77 |
|
|
2023
Q3 | $20.2M | Buy |
590,575
+163,650
| +38% | +$5.59M | 0.31% | 116 |
|
|
2023
Q2 | $16.4M | Buy |
426,925
+19,130
| +5% | +$737K | 0.24% | 134 |
|
|
2023
Q1 | $14.6M | Sell |
407,795
-74,385
| -15% | -$2.66M | 0.21% | 144 |
|
|
2022
Q4 | $19M | Buy |
+482,180
| New | +$19M | 0.27% | 134 |
|